CryoLife to Present at MedTech Insight's In Spine & Orthopedics Conference in Las Vegas

ATLANTA, Dec. 11 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), a biomaterials and biosurgical device company, announced today that it is scheduled to participate in the MedTech Insight In Spine & Orthopedics Meeting at the Venetian Resort Hotel-Casino in Las Vegas on Tuesday, December 12, 2006.

Gerald B. Seery, Senior Vice President, Sales and Marketing, CryoLife, Inc., will deliver the Company's presentation at 2:25 p.m. PST.

About CryoLife

Founded in 1984, CryoLife, Inc. is a leader in the processing and distribution of implantable living human tissues for use in cardiovascular, vascular, and orthopaedic surgeries throughout the United States and Canada. The Company's BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. BioGlue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. The Company also distributes the CryoLife-O'Brien(R) stentless porcine heart valve and the SG Model 100 vascular graft, which are CE marked for distribution within the European Community.

For additional information about the Company, visit CryoLife's Web Site:
http://www.cryolife.com

Media Contacts:

D. Ashley Lee,
Executive Vice President,
Chief Financial Officer and Chief Operating Officer of CryoLife, Inc.,
+1-770-419-3355;
or Katie Brazel of Fleishman Hillard,
+1-404-739-0150
SOURCE CryoLife, Inc.
Web site: http://www.cryolife.com
(CRY)